BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 8570183)

  • 1. Structural requirements for the efficient regulation of the Src protein tyrosine kinase by Csk.
    Koegl M; Courtneidge SA; Superti-Furga G
    Oncogene; 1995 Dec; 11(11):2317-29. PubMed ID: 8570183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of bovine thymus cytosolic C-terminal Src kinase (CSK) and demonstration of differential efficiencies of phosphorylation and inactivation of p56lyn and pp60c-src by CSK.
    Cheng HC; Bjorge JD; Aebersold R; Fujita DJ; Wang JH
    Biochemistry; 1996 Sep; 35(36):11874-87. PubMed ID: 8794770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Domain interactions in protein tyrosine kinase Csk.
    Sondhi D; Cole PA
    Biochemistry; 1999 Aug; 38(34):11147-55. PubMed ID: 10460171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing the communication between the regulatory and catalytic domains of a protein tyrosine kinase, Csk.
    Lin X; Ayrapetov MK; Lee S; Parang K; Sun G
    Biochemistry; 2005 Feb; 44(5):1561-7. PubMed ID: 15683240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the regulatory domains of the Src-family tyrosine kinase Lck.
    Eck MJ; Atwell SK; Shoelson SE; Harrison SC
    Nature; 1994 Apr; 368(6473):764-9. PubMed ID: 7512222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 2.35 A crystal structure of the inactivated form of chicken Src: a dynamic molecule with multiple regulatory interactions.
    Williams JC; Weijland A; Gonfloni S; Thompson A; Courtneidge SA; Superti-Furga G; Wierenga RK
    J Mol Biol; 1997 Dec; 274(5):757-75. PubMed ID: 9405157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Csk inhibition of c-Src activity requires both the SH2 and SH3 domains of Src.
    Superti-Furga G; Fumagalli S; Koegl M; Courtneidge SA; Draetta G
    EMBO J; 1993 Jul; 12(7):2625-34. PubMed ID: 7687537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SH2 domain-mediated interaction of inhibitory protein tyrosine kinase Csk with protein tyrosine phosphatase-HSCF.
    Wang B; Lemay S; Tsai S; Veillette A
    Mol Cell Biol; 2001 Feb; 21(4):1077-88. PubMed ID: 11158295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of c-Src tyrosine kinase activity by the Src SH2 domain.
    Liu X; Brodeur SR; Gish G; Songyang Z; Cantley LC; Laudano AP; Pawson T
    Oncogene; 1993 May; 8(5):1119-26. PubMed ID: 7683128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous autophosphorylation of Lyn tyrosine kinase at both its activation segment and C-terminal tail confers altered substrate specificity.
    Donella-Deana A; Cesaro L; Ruzzene M; Brunati AM; Marin O; Pinna LA
    Biochemistry; 1998 Feb; 37(5):1438-46. PubMed ID: 9477973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subdomain switching reveals regions that harbor substrate specificity and regulatory properties of protein tyrosine kinases.
    Wang YH; Huang K; Lin X; Sun G
    Biochemistry; 2007 Sep; 46(35):10162-9. PubMed ID: 17691821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophosphorylation of Src and Yes blocks their inactivation by Csk phosphorylation.
    Sun G; Sharma AK; Budde RJ
    Oncogene; 1998 Sep; 17(12):1587-95. PubMed ID: 9794236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide and protein phosphorylation by protein tyrosine kinase Csk: insights into specificity and mechanism.
    Sondhi D; Xu W; Songyang Z; Eck MJ; Cole PA
    Biochemistry; 1998 Jan; 37(1):165-72. PubMed ID: 9425036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of Src mutants at Tyr 527 in fibroblasts does not correlate with in vitro phosphorylation by CSK.
    MacAuley A; Okada M; Nada S; Nakagawa H; Cooper JA
    Oncogene; 1993 Jan; 8(1):117-24. PubMed ID: 7678701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of C-terminal Src kinase (Csk) by phosphorylation at serine-364 depends on the Csk-Src homology 3 domain.
    Yaqub S; Abrahamsen H; Zimmerman B; Kholod N; Torgersen KM; Mustelin T; Herberg FW; Taskén K; Vang T
    Biochem J; 2003 May; 372(Pt 1):271-8. PubMed ID: 12600271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Csk-binding protein (Cbp) negatively regulates epidermal growth factor-induced cell transformation by controlling Src activation.
    Jiang LQ; Feng X; Zhou W; Knyazev PG; Ullrich A; Chen Z
    Oncogene; 2006 Sep; 25(40):5495-506. PubMed ID: 16636672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural elements and allosteric mechanisms governing regulation and catalysis of CSK-family kinases and their inhibition of Src-family kinases.
    Ia KK; Mills RD; Hossain MI; Chan KC; Jarasrassamee B; Jorissen RN; Cheng HC
    Growth Factors; 2010 Oct; 28(5):329-50. PubMed ID: 20476842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for domain-domain communication in a protein tyrosine kinase, the C-terminal Src kinase.
    Lin X; Wang Y; Ahmadibeni Y; Parang K; Sun G
    J Mol Biol; 2006 Apr; 357(4):1263-73. PubMed ID: 16483606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myristylation and amino-terminal phosphorylation are required for activation of pp60c-src during mitosis.
    Kaech S; Schnierle B; Wyss A; Ballmer-Hofer K
    Oncogene; 1993 Mar; 8(3):575-81. PubMed ID: 7679790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SH3 and SH2 domains are capable of directing specificity in protein interactions between the non-receptor tyrosine kinases cSrc and cYes.
    Summy JM; Guappone AC; Sudol M; Flynn DC
    Oncogene; 2000 Jan; 19(1):155-60. PubMed ID: 10644991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.